Literature DB >> 12138264

Cytokine mRNA profile in lipoid nephrosis: evidence for increased IL-8 mRNA stability.

Paul F Laflam1, Soichi Haraguchi, Eduardo H Garin.   

Abstract

BACKGROUND/AIMS: Proteinuria in idiopathic minimal lesion nephrotic syndrome (IMLNS) is presumed to be due to the effect of circulating factors on glomerular permeability to plasma proteins. This study examines the expression of messenger ribonucleic acid (mRNA) for cytokines thought to mediate glomerular inflammation during different stages of the nephrotic syndrome.
METHODS: Messenger RNA expression and stability from peripheral blood mononuclear cells of IMLNS patients in relapse and in remission, and age matched normal controls were measured using a ribonuclease protection assay (RPA). The spontaneous and Interleukin 2 (IL-2) stimulated mRNA expression were studied.
RESULTS: Spontaneous mRNA expression for Interleukin 8 (IL-8) from IMLNS patients in relapse was significantly increased when compared to IMLNS patients in remission and normal controls (p < 0.05). After 14 h of IL-2 stimulation, mRNA IL-8 levels expressed by IMLNS PBMC patients in remission were not different from those observed in normal controls. However, after 5 days of PBMC incubation, a significant increase in mRNA for IL-8 in IMLNS patients compared to controls was found (p < 0.01). Stability assay demonstrated that IL-8 mRNA transcript from the nephrotic patients remained higher than those from controls and showed a significantly prolonged life t(1/2) (p = 0.02).
CONCLUSIONS: IL-8 mRNA expression is increased in IMLNS patients in relapse. Moreover, stability studies show that IL-8 mRNA life t(1/2) is prolonged due to altered post-transcriptional regulation. This finding may explain the elevated serum IL-8 levels observed in these patients during relapse and may have pathogenic significance since IL-8 has been shown to induce proteinuria in the experimental animal. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138264     DOI: 10.1159/000065022

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

1.  T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos Araya; Leila Diaz; Clive Wasserfall; Mark Atkinson; Wei Mu; Richard Johnson; Eduardo Garin
Journal:  Pediatr Nephrol       Date:  2009-06-03       Impact factor: 3.714

2.  Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3'-untranslated region.

Authors:  Karthikeyan Kandasamy; Andrew S Kraft
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

3.  Up-regulation of interleukin-2 mRNA in children with idiopathic nephrotic syndrome.

Authors:  Hironobu Shimoyama; Mitsuru Nakajima; Hiroyuki Naka; Yoshiyuki Maruhashi; Hideki Akazawa; Taku Ueda; Masayuki Nishiguchi; Yoko Yamoto; Hidekazu Kamitsuji; Akira Yoshioka
Journal:  Pediatr Nephrol       Date:  2004-08-07       Impact factor: 3.714

Review 4.  A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos E Araya; Clive H Wasserfall; Todd M Brusko; Wei Mu; Mark S Segal; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

5.  Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?

Authors:  Arnold H Zea; Tyrus Stewart; Jeannine Ascani; David J Tate; Beatriz Finkel-Jimenez; Anna Wilk; Krzysztof Reiss; William E Smoyer; Diego H Aviles
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.